Jupiter Neurosciences, Inc. (JUNS) Ownership

NASDAQ: JUNSTop holders, insider trades and short interest.

JUNS ownership summary

as of October 18, 2026
Institutions
2.2%
of shares outstanding
Insiders
29.96%
of shares outstanding
Shares outstanding
1.3M
Float
564K
shares available to trade
Short interest
3.12%
35K shares short
Days to cover
0.55
short interest down 32.5% vs prior month
  • Institutions 2.25%
  • Insiders 29.96%
  • Other investors 67.79%

JUNS top institutional holders

17 largest
Jupiter Neurosciences, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Virtu Financial LLC0.23%231K$671,752+217,665 (+1,603.4%)June 30, 2026
2Geode Capital Management, LLC0.16%156K$453,549−55,569 (−26.2%)June 30, 2026
3Vanguard Capital Management, LLC0.13%128K$371,962−231,869 (−64.4%)June 30, 2026
4Vanguard Fiduciary Trust Co0.09%84K$244,523−3,616 (−4.1%)June 30, 2026
5Northern Trust Corp0.03%25K$73,630—June 30, 2026
6Vestor Capital Partners<0.01%2,193$6,371−968,792 (−99.8%)June 30, 2026
7Midfirst Bank<0.01%1,000$2,905—June 30, 2026
8Citigroup Inc<0.01%546$1,586+546 (0.0%)June 30, 2026
9Susquehanna International Group, LLP0.00%——−29,274 (−100.0%)March 31, 2026
10Acadian Asset Management LLC0.00%——−3,000 (−100.0%)March 31, 2026
11Yorkville Advisors Global, LP0.00%——−129,000 (−100.0%)June 30, 2026
12Jane Street Group LLC0.00%——−14,457 (−100.0%)March 31, 2026
13Citadel Advisors Llc0.00%——−101,661 (−100.0%)June 30, 2026
14UBS Group AG0.00%——−3,928 (−100.0%)June 30, 2026
15Allen Capital Group, LLC0.00%——−30,000 (−100.0%)March 31, 2026
16XTX Topco Ltd0.00%——−21,500 (−100.0%)March 31, 2026
17Bank of America Corp0.00%——−142 (−100.0%)March 31, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 17, 2 holders added 218K shares and 13 cut 1.6M.

JUNS top mutual fund and ETF holders

3 largest
Jupiter Neurosciences, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Fidelity Extended Market Index0.09%1,130$3,283—August 31, 2026
2Fidelity Series Total Market Index0.02%239$694−1 (−0.4%)August 31, 2026
3Fidelity Total Market Index0.02%214$622—August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

JUNS insider transactions

latest 3
Jupiter Neurosciences, Inc. insider transactions
DateNameTransactionPriceSharesValue
2025-07-01Alison D SilvaBuy$1.03750$772
2025-06-30Alison D SilvaBuy$1.03950$978
2025-06-27Alison D SilvaBuy$1.03850$876

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

JUNS shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns JUNS

Institutional investors own 2.2% of Jupiter Neurosciences's shares and insiders 29.96%. The largest holder is Virtu Financial LLC with 0.23% of the shares (231K), as of June 30, 2026. Among the top 17 institutions, 2 added shares and 13 reduced their stake in the latest filings. Short interest is 3.12% of the float, or 0.55 days of average trading volume. The share count rose 288.3% since 2020.

Related: JUNS analyst forecast, JUNS key metrics. See the JUNS stock overview for the latest quote and news.

JUNS ownership FAQ

Who owns the most Jupiter Neurosciences stock?

The largest shareholders of Jupiter Neurosciences are Virtu Financial LLC (0.23%), Geode Capital Management, LLC (0.16%), Vanguard Capital Management, LLC (0.13%), Vanguard Fiduciary Trust Co (0.09%), Northern Trust Corp (0.03%).

What percentage of Jupiter Neurosciences is owned by institutions?

Institutions hold 2.2% of Jupiter Neurosciences's shares outstanding; insiders hold 29.96%.

Which funds own Jupiter Neurosciences?

The largest fund holders of Jupiter Neurosciences are Fidelity Extended Market Index (0.09%), Fidelity Series Total Market Index (0.02%), Fidelity Total Market Index (0.02%).

What is Jupiter Neurosciences's short interest?

35K shares of Jupiter Neurosciences were sold short, 3.12% of the float; at the average daily volume it would take 0.55 days to cover.

Are insiders buying or selling Jupiter Neurosciences?

Of the latest 3 reported insider transactions in Jupiter Neurosciences (since June 27, 2025), 3 were purchases and 0 were sales.

How many shares of Jupiter Neurosciences are outstanding?

Jupiter Neurosciences has 1.3M shares outstanding, of which 564K are in the public float.

Biotechnology: ownership